The performance characteristics of prostate-specific antigen and prostate-specific antigen density in tOChinese men

被引:10
作者
Teoh, Jeremy Y. C. [1 ]
Yuen, Steffi K. K. [1 ]
Tsu, James H. L. [1 ]
Wong, Charles K. W. [1 ]
Ho, Brian S. H. [1 ]
Ng, Ada T. L. [1 ]
Ma, Wai-Kit [1 ]
Ho, Kwan-Lun [1 ]
Yiu, Ming-Kwong [1 ]
机构
[1] Univ Hong Kong, Queen Mary Hosp, Dept Surg, Div Urol, Hong Kong, Hong Kong, Peoples R China
关键词
Chinese; prostate cancer; transrectal ultrasound-guided prostate biopsy; prostate-specific antigen; prostate-specific antigen density; OPERATING CHARACTERISTIC CURVES; CANCER; PSA;
D O I
10.4103/1008-682X.167103
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
We investigated the performance characteristics of prostate-specific antigen (PSA) and PSA density (PSAD) in Chinese men. All Chinese men who underwent transrectal ultrasound-guided prostate biopsy (TRUS-PB) from year 2000 to 2013 were included. The receiver operating characteristic (ROC) curves for both PSA and PSAD were analyzed. The sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) at different cut-off levels were calculated. A total of 2606 Chinese men were included. For the ROC, the area under curve was 0.770 for PSA (P < 0.001) and 0.823 for PSAD (P < 0.001). PSA of 4.5 ng mi-1 had sensitivity of 94.4%, specificity of 14.1%, PPV of 29.5%, and NPV of 86.9%; PSAD of 0.12 ng ml(-1) cc(-1) had sensitivity of 94.5%, specificity of 26.6%, PPV of 32.8%, and NPV of 92.7%. On multivariate logistic regression analyses, PSA cut-off at 4.5 ng ml(-1) (OR 1.61, 95% CI 1.05-2.45, P = 0.029) and PSAD cut-off at 0.12 ng ml(-1) cc(-1) (OR 6.22, 95% CI 4.20-9.22, P < 0.001) were significant predictors for prostate cancer detection on TRUS-PB. In conclusion, the performances of PSA and PSAD at different cut-off levels in Chinese men were very different from those in Caucasians. PSA of 4.5 ng ml(-1) and PSAD of 0.12 ng ml(-1) cc(-1) had near 95% sensitivity and were significant predictors of prostate cancer detection in Chinese men.
引用
收藏
页码:113 / 116
页数:4
相关论文
共 17 条
[11]  
Kawachi MH, 2010, J NATL COMPR CANC NE, V8, P240, DOI 10.6004/jnccn.2010.0016
[12]   Prostate specific antigen density. Is there a role for this parameter when screening for prostate cancer? [J].
Lujan, M ;
Paez, A ;
Llanes, L ;
Miravalles, E ;
Berenguer, A .
PROSTATE CANCER AND PROSTATIC DISEASES, 2001, 4 (03) :146-149
[13]   The value of prostate-specific antigen in Asia [J].
Mochtar, Chaidir Arif ;
Andika, R. Siddhi .
THERAPEUTIC ADVANCES IN UROLOGY, 2010, 2 (02) :77-83
[14]  
NADJI M, 1981, CANCER-AM CANCER SOC, V48, P1229, DOI 10.1002/1097-0142(19810901)48:5<1229::AID-CNCR2820480529>3.0.CO
[15]  
2-L
[16]   SERUM PROSTATE-SPECIFIC ANTIGEN IN A COMMUNITY-BASED POPULATION OF HEALTHY JAPANESE MEN - LOWER VALUES THAN FOR SIMILARLY AGED WHITE MEN [J].
OESTERLING, JE ;
KUMAMOTO, Y ;
TSUKAMOTO, T ;
GIRMAN, CJ ;
GUESS, HA ;
MASUMORI, N ;
JACOBSEN, SJ ;
LIEBER, MM .
BRITISH JOURNAL OF UROLOGY, 1995, 75 (03) :347-353
[17]   Prostate-specific antigen (PSA) and PSA velocity for prostate cancer detection in men aged &lt;50 years [J].
Sun, Leon ;
Moul, Judd W. ;
Hotaling, James M. ;
Rampersaud, Edward ;
Dahm, Phillipp ;
Robertson, Cary ;
Fitzsimons, Nicholas ;
Albala, David ;
Polascik, Thomas J. .
BJU INTERNATIONAL, 2007, 99 (04) :753-757